Salutary effect of NFκB inhibitor and folacin in hyperhomocysteinemia-hyperlipidemia induced vascular dementia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 38, Issue 2, 2012, Pages 207-215

  Sharma, Bhupesh ^a   Singh, Nirmal ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Alzheimer's disease; Cholesterol; L methionine; Morris water maze; Natrium diethyl dithio carbamate trihydrate; Vitamin B9

Indexed keywords

ACETYLCHOLINESTERASE; CHOLESTEROL; DIETHYLDITHIOCARBAMIC ACID; DONEPEZIL; FOLIC ACID; GLUTATHIONE; HOMOCYSTEINE; METHIONINE; NITRATE; NITRITE; SUPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CHOLESTEROL BLOOD LEVEL; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; LEARNING DISORDER; LOW DRUG DOSE; MALE; MAZE TEST; MEMORY DISORDER; MULTIINFARCT DEMENTIA; NONHUMAN; OXIDATIVE STRESS; RAT;

ACETYLCHOLINESTERASE; ANIMALS; DEMENTIA, VASCULAR; DITIOCARB; ENDOTHELIUM, VASCULAR; FOLIC ACID; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIAS; MALE; MAZE LEARNING; METHIONINE; NF-KAPPA B; OXIDATIVE STRESS; RATS; RATS, WISTAR;

EID: 84862867232     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.03.013     Document Type: Article

References (47)

1. Ansari M.N., Nigam G.K., Bhandari U. Effect of folic acid on hematological changes in methionine-induced hyperhomocysteinemia in rats. Indian J Pharm Sci 2009, 71(3):270-275.
2. Anthony J.D., Gary L.P., Lisa A.L., Douglas R.S. Role of NFκB in age-related vascular endothelial dysfunction in humans. Aging 2009, 1(8):678-680.
3. Balk E., Chung M., Raman G., Tatsioni A., Chew P., Ip S., et al. B vitamins and berries and age-related neurodegenerative disorders. Evid Rep Technol Assess 2006, 134:1-161.
4. Beutler E., Duron O., Kelly B. Reduced glutathione estimation. J Lab Clin Med 1963, 61:82.
5. Daviglus M.L., Plassman B.L., Pirzada A., Bell C.C., Bowen P.E., Burke J.R., et al. Risk factors and preventive interventions for Alzheimer disease, state of the science. Arch Neurol 2011, 68(9):1185-1190.
6. Dimitrova K.R., Degroot K.W., Pacquing A.M., Suyderhoud J.P., Pirovic E.A., Murno T.J., et al. Estradiol prevents homocysteine induced endothelial injury in male rats. Cardiovasc Res 2002, 53:589-596.
7. Ellman G.L., Courtney D.K., Andres V., Feathstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961, 7:88-95.
8. Enciu A.M., Constantinescu S.N., Popescu L.M., Mureşanu D.F., Popescu B.O. Neurobiology of vascular dementia. J Aging Res 2011, 2011:401604.
9. Ferlazzo N., Condello S., Currò M., Parisi G., Ientile R., Caccamo D. NF-kappaB activation is associated with homocysteine-induced injury in Neuro2a cells. BMC Neurosci 2008, 9:62.
10. Frisardi V., Solfrizzi V., Seripa D., Capurso C., Santamato A., Sancarlo D., et al. Metabolic-cognitive syndrome, a cross-talk between metabolic syndrome and Alzheimer's disease. Ageing Res Rev 2010, 9(4):399-417.
11. Gao L., Zeng X.N., Guo H.M., Wu X.M., Chen H.J., Di R.K., et al. Cognitive and neurochemical alterations in hyperhomocysteinemic rat. Neurol Sci 2012, 33(1):39-43.
12. Granic I., Dolga A.M., Nijholt I.M., Van Dijk G., Eisel U.L. Inflammation and NF-kappaB in Alzheimer's disease and diabetes. J Alzheimers Dis 2009, 16(4):809-821.
13. Herrmann W., Obeid R. Homocysteine, a biomarker in neurodegenerative diseases. Clin Chem Lab Med 2011, 49(3):435-441.
14. Jablonski K.L., Chonchol M., Pierce G.L., Walker A.E., Seals D.R. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 2011, 57(1):63-69.
15. Kalaria R.N. Vascular basis for brain degeneration faltering controls and risk factors for dementia. Nutr Rev 2010, 68(2):S74-S87.
16. Kim T.I., Lee Y.K., Park S.G., Choi I.S., Ban J.O., Park H.K., et al. l-Theanine an amino acid in green tea attenuates beta-amyloid-induced cognitive dysfunction and neurotoxicity reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-kappaB pathways. Free Radic Biol Med 2009, 47(11):1601-1610.
17. Kim M.K., Chung S.W., Kim D.H., Kim J.M., Lee E.K., Kim J.Y., et al. Modulation of age-related NF-kappaB activation by dietary zingerone via MAPK pathway. Exp Gerontol 2010, 45(6):419-426.
18. Koladiya R.U., Jaggi A.S., Singh N., Sharma B.K. Ameliorative role of atorvastatin and pitavastatin in l-methionine induced vascular dementia in rats. BMC Pharmacol 2008, 8:14.
19. Koladiya R.U., Jaggi A.S., Singh N., Sharma B.K. Beneficial effects of donepezil on vascular endothelial dysfunction-associated dementia induced by l-methionine in rats. J. Health Sci 2009, 552:215-225.
20. Kolling J., Scherer E.B., da Cunha A.A., da Cunha M.J., Wyse A.T. Homocysteine induces oxidative-nitrative stress in heart of rats, prevention by folic acid. Cardiovasc Toxicol 2011, 11(1):67-73.
21. Kronenberg G., Colla M., Endres M. Folic acid, neurodegenerative and neuropsychiatric disease. Curr Mol Med 2009, 9(3):315-323.
22. Kuhad A., Bishnoi M., Tiwari V., Chopra K. Suppression of NF-kappabeta signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits. Pharmacol Biochem Behav 2009, 92(2):251-259.
23. Lan T.H., Xu Z.W., Wang Z., Wu Y.L., Wu W.K., Tan H.M. Ginsenoside Rb1 prevents homocysteine-induced endothelial dysfunction via PI3K/Akt activation and PKC inhibition. Biochem Pharmacol 2011, 82(2):148-155.
24. Lowry O.H., Rosebrough N.J., Far A.L., Randall R.J. Protein measurement with folin-phenol reagent. J Biol Chem 1951, 193:265-275.
25. Malouf R., Grimley E.J. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev 2008, (4):CD004514.
26. Monsuez J.J., Gesquière-Dando A., Rivera S. Cardiovascular prevention of cognitive decline. Cardiol Res Pract 2011, 2011:250970.
27. Morris R.G.M. Developments of a water maze producer for studying spatial learning in the rats. J Neurosci Methods 1984, 11:47-60.
28. Muhammad A.B., Lokhandwala M.F., Banday A.A. Exercise reduces oxidative stress but does not alleviate hyperinsulinemia or renal dopamine D1 receptor dysfunction in obese rats. Am J Physiol Renal Physiol 2011, 300(1):F98-F104.
29. Ohokawa H., Ohishi N., Yagi K. Assay for lipid peroxided in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
30. Park C.M., Cho C.W., Rosenfeld M.E., Song Y.S. Methionine supplementation accelerates oxidative stress and nuclear factor kappaB activation in livers of C57BL/6 mice. J Med Food 2008, 11(4):667-674.
31. Parle M., Singh N. Reversal of memory deficits by Atorvastatin and Simvastatin in rats. Yakugaku Zasshi 2007, 127(7):1125-1137.
32. Prasanna G.S., Ashok P. Antihyperhomocysteinemic and antihyperlipidemic effect of Trichilia connaroides in methionine-induced hyperhomocysteinemic animals. Indian J Pharmacol 2011, 43(2):203-206.
33. Qipshidze N., Metreveli N., Lominadze D., Tyagi S.C. Folic acid improves acetylcholine-induced vasoconstriction of coronary vessels isolated from hyperhomocysteinemic mice, an implication to coronary vasospasm. J Cell Physiol 2011, 226(10):2712-2720.
34. Sain H., Sharma B., Jaggi A.S., Singh N. Pharmacological investigations on potential of peroxisome proliferator-activated receptor-gamma agonists in hyperhomocysteinemia-induced vascular dementia in rats. Neuroscience 2011, 192:322-333.
35. Sanz A.B., Sanchez-Niño M.D., Ramos A.M., Moreno J.A., Santamaría B., Ruiz-Ortega M., et al. NF-kappaB in renal inflammation. J Am Soc Nephrol 2010, 21(8):1254-1262.
36. Sastry K.V., Moudgal R.P., Mohan J., Tyagi J.S., Rao G.S. Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy. Anal Biochem 2002, 306(1):79-82.
37. Sharma B., Singh N. Pitavastatin and 4'-hydroxy-3'-methoxyacetophenone HMAP reduce cognitive dysfunction in vascular dementia during experimental diabetes. Curr Neurovasc Res 2010, 7(3):180-191.
38. Sharma B., Singh N. Attenuation of vascular dementia by sodium butyrate in streptozotocin diabetic rats. Psychopharmacology 2011, 215(4):677-687.
39. Sharma B., Singh N. Behavioral and biochemical investigations to explore pharmacological potential of PPAR-gamma agonists in vascular dementia of diabetic rats. Pharmacol Biochem Behav 2011, 100(2):320-329.
40. Sharma B., Singh N., Singh M. Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by Pitavastatin and Donepezil. J Psychopharmacol 2008, 22(2):162-171.
41. Sharma B., Singh N., Singh M., Jaggi A.S. Exploitation of HIV protease inhibitor Indinavir as a memory restorative agent in experimental dementia. Pharmacol Biochem Behav 2008, 89(4):535-545.
42. Ullrich C., Pirchl M., Humpel C. Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits. Mol Cell Neurosci 2010, 45(4):408-417.
43. Wang H.D., Pagano P.J., Du Y. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ Res 1998, 82:810-818.
44. Wehling M., Groth H. Challenges of longevity in developed countries vascular prevention of dementia as an immediate clue to tackle an upcoming medical social and economic stretch. Neurodegener Dis 2011, 8(5):275-282.
45. Wu N., Siow Y.L., O, K. Induction of hepatic cyclooxygenase-2 by hyperhomocysteinemia via nuclear factor-kappaB activation. Am J Physiol Regul Integr Comp Physiol 2009, 297(4):R1086-R1094.
46. Xu Y., Tian Y., Wei H.J., Dong J.F., Zhang J.N. Methionine diet-induced hyperhomocysteinemia accelerates cerebral aneurysm formation in rats. Neurosci Lett 2011, 494(2):139-144.
47. Yunoki K., Nakamura K., Miyoshi T., Enko K., Kubo M., Murakami M., et al. Impact of hypertriglyceridemia on endothelial dysfunction during statin±ezetimibe therapy in patients with coronary heart disease. Am J Cardiol 2011, 108(3):333-339.